Skip to content

DEL PHARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DEL PHARMA

BE 0721.527.966
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€5,967
2024 · €2,119+€3,848
Equity
€16,307
2024 · €10,340+€5,967
Cash
€2,141
2024 · €686+€1,455
Balance sheet total
€36,943
2024 · €33,315+€3,628

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€6,570

    up €6,570 (+40.7%), from €16,124 to €22,694

    of which Other amounts receivable: +€5,448

  • Tangible fixed assets -€6,431

    down €6,431 (-39.0%), from €16,506 to €10,074

  • Deferred charges and accrued income +€2,034

    new in 2025: €2,034

  • Cash +€1,455

    up €1,455 (+212.3%), from €686 to €2,141

    mainly Depreciation (+€7,613) and Net result for the year (+€5,967)

Equity and liabilities
  • Debts after one year -€5,982

    no longer reported in 2025 (was €5,982)

  • Reserves +€5,967

    up €5,967 (+41.2%), from €14,500 to €20,467

  • Tax, wage and social debts +€4,722

    up €4,722 (+49.7%), from €9,501 to €14,224

    of which Taxes: +€2,572

  • Current portion of long-term debt -€1,509

    down €1,509 (-20.1%), from €7,491 to €5,982

Income statement
  • Gross operating margin +€5,266

    up €5,266 (+37.9%), from €13,908 to €19,174

  • Taxes +€1,382

    up €1,382 (+43.3%), from €3,189 to €4,571

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €2,119
Gross operating margin +€5,266
Staff costs -€81
Depreciation -€13
Other operating charges -€18
Financial charges +€76
Taxes -€1,382
Result 2025 €5,967

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€10,129
Investment -€1,182
Financing -€7,491
Cash 2024 €686
Net result for the year +€5,967
Depreciation +€7,613
Receivables within one year -€6,570
Deferred charges and accrued income -€2,034
Trade debts +€180
Tax, wage and social debts +€4,722
Accrued charges and deferred income +€250
Investment in fixed assets (net) -€1,182
Debts after one year -€5,982
Current portion of long-term debt -€1,509
Cash 2025 €2,141
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €33,315 €36,943 +€3,628 +10.9%
Fixed assets 21/28 €16,506 €10,074 -€6,431 -39.0%
Tangible fixed assets 22/27 €16,506 €10,074 -€6,431 -39.0%
Furniture and vehicles 24 €16,506 €10,074 -€6,431 -39.0%
Current assets 29/58 €16,810 €26,869 +€10,059 +59.8%
Amounts receivable within one year 40/41 €16,124 €22,694 +€6,570 +40.7%
Trade receivables 40 €9,154 €10,276 +€1,122 +12.3%
Other amounts receivable 41 €6,970 €12,418 +€5,448 +78.2%
Cash at bank and in hand 54/58 €686 €2,141 +€1,455 +212.3%
Deferred charges and accrued income 490/1 - €2,034 +€2,034
Total equity and liabilities 10/49 €33,315 €36,943 +€3,628 +10.9%
Equity 10/15 €10,340 €16,307 +€5,967 +57.7%
Contributions 10/11 €5,000 €5,000 = 0.0%
Outside capital 11 €5,000 €5,000 = 0.0%
Other 1109/19 €5,000 €5,000 = 0.0%
Reserves 13 €14,500 €20,467 +€5,967 +41.2%
Non-distributable reserves 130/1 €14,500 €20,467 +€5,967 +41.2%
Reserves not available under the articles 1311 €500 €500 = 0.0%
Other 1319 €14,000 €19,967 +€5,967 +42.6%
Profit (loss) carried forward 14 -€9,160 -€9,160 = 0.0%
Amounts payable 17/49 €22,975 €20,636 -€2,339 -10.2%
Amounts payable after more than one year 17 €5,982 - -€5,982
Financial debts 170/4 €5,982 - -€5,982
Amounts payable within one year 42/48 €16,993 €20,386 +€3,393 +20.0%
Current portion of amounts payable after more than one year 42 €7,491 €5,982 -€1,509 -20.1%
Trade debts 44 - €180 +€180
Suppliers 440/4 - €180 +€180
Taxes, remuneration and social security 45 €9,501 €14,224 +€4,722 +49.7%
Taxes 450/3 €9,501 €12,074 +€2,572 +27.1%
Remuneration and social security 454/9 - €2,150 +€2,150
Accrued charges and deferred income 492/3 - €250 +€250
Remuneration, social security and pensions 62 - €81 +€81
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,601 €7,613 +€13 +0.2%
Other operating charges 640/8 €564 €582 +€18 +3.3%
Gross operating margin 9900 €13,908 €19,174 +€5,266 +37.9%
Operating profit (loss) 9901 €5,743 €10,897 +€5,154 +89.7%
Financial charges 65/66B €435 €359 -€76 -17.4%
Recurring financial charges 65 €435 €359 -€76 -17.4%
Profit (loss) for the period before taxes 9903 €5,308 €10,538 +€5,230 +98.5%
Income taxes 67/77 €3,189 €4,571 +€1,382 +43.3%
Profit (loss) for the period 9904 €2,119 €5,967 +€3,848 +181.6%
Profit (loss) for the period to be appropriated 9905 €2,119 €5,967 +€3,848 +181.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.